A retrospective real-world study on hospitalized patients with T2D (n=2,356) reported insulin therapy linked to a high risk of carotid atherosclerotic plaque, including macrovascular complications, even after adjusting for the CV risk factors [67]. The gene discussed is INS; the disease is type 2 diabetes mellitus.